Serina Therapeutics (SER) Enterprise Value (2018 - 2026)

Serina Therapeutics has disclosed Enterprise Value across 9 years of filings, most recently posting $8.8 million for Q2 2026.

• In Q2 2026, Enterprise Value fell 84.43% year-over-year to $8.8 million; the TTM figure through Jun 2026 stood at $8.8 million (down 84.43% YoY), while the FY2025 annual figure was $17.5 million, down 47.04% from the prior year.
• Enterprise Value came in at $8.8 million for Q2 2026 at Serina Therapeutics, down from $17.5 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $1.2 billion in Q2 2023 to a low of $8.8 million in Q2 2026.
• Average Enterprise Value over 5 years is $405.7 million, with a median of $56.3 million recorded in 2025.
• Year-over-year, Enterprise Value tumbled 96.79% in 2024 and jumped 79.82% in 2025.
• Over 5 years, Enterprise Value stood at $747.2 million in 2022, then slumped by 94.16% to $43.6 million in 2023, then fell by 24.2% to $33.1 million in 2024, then sank by 47.04% to $17.5 million in 2025, then sank by 49.95% to $8.8 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $8.8 million in Q2 2026, $17.5 million in Q4 2025, and $47.7 million in Q3 2025.